التفاصيل البيبلوغرافية
العنوان:
Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
المؤلفون:
Duncan C. Gilbert , Joanna Gale , Nicholas D. James , Shaun Tolan , Claire Amos , Robin Millman , Zafar Malik , G. Attard , James D. Wylie , Anjali Zarkar , S. Rudman , Robert Jones , Anna Lydon , Noel W. Clarke , Chris Parker , Joe M O'Sullivan , Jan Wallace , Aurelius Omlin , Alison Birtle , Adrian Cook , Archie Macnair , Malcolm David Mason , A.W.S. Ritchie , Matthew S. Simms , Alex Hoyle , Adnan Ali , H. Rush , John Wagstaff , Christopher D. Brawley , Jacob Tanguay , Andrew Protheroe , Silke Gillessen , Ruth E Langley , F.C. Ingleby , Omi Parikh , Stephanie Gibbs , David P. Dearnaley , David Matheson , Matthew R. Sydes , William Cross , Simon Chowdhury , L. Capaldi , Sharon Beesley , J. Calvert , Janet E. Brown , J.M. Russell , Hassan Douis , Narayanan Srihari , A. Nikapota , Mona Parmar , Stampede Investigators
المصدر:
Annals of Oncology . 31:442
بيانات النشر:
Elsevier BV, 2020.
سنة النشر:
2020
مصطلحات موضوعية:
Oncology , medicine.medical_specialty , business.industry , MEDLINE , Hematology , Hormone sensitive prostate cancer , Docetaxel , Internal medicine , Long term survival , medicine , Hormonal therapy , business , medicine.drug
تدمد:
0923-7534
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_________::47b985e6be9b562abd6b7317e5eed22c https://doi.org/10.1016/j.annonc.2020.01.002
حقوق:
OPEN
رقم الأكسشن:
edsair.doi...........47b985e6be9b562abd6b7317e5eed22c
قاعدة البيانات:
OpenAIRE
